[Form 4] Merus N.V. Insider Trading Activity
Rhea-AI Filing Summary
Merus N.V. discloses that a director participated in the cash tender offer launched by Genmab’s subsidiary for all issued and outstanding Merus common shares. On December 12, 2025, the director tendered 73,576 common shares, which were accepted at a cash price of $97.00 per share, leaving the director with no remaining common shares after the transaction.
The report also explains that several Merus stock options held by the director, covering blocks of shares such as 13,193, 8,844 and 14,414, with exercise prices including $41.60, $48.73 and $23.29 per share, were cancelled under the transaction agreement. In each case, the option was exchanged for cash equal to the amount by which the $97.00 offer price exceeded the option’s exercise price, multiplied by the number of underlying shares, so the director now reports holding no derivative securities.
Positive
- None.
Negative
- None.
Insights
Director tenders all Merus equity into Genmab’s $97 cash offer.
This report shows how a Merus N.V. director’s equity was treated in the change-of-control transaction with Genmab A/S. The director tendered 73,576 common shares into a tender offer for all issued and outstanding shares at $97.00 per share, accepted on December 12, 2025. After this tender, the director no longer owns Merus common shares.
The filing further details the treatment of stock options. Multiple options with exercise prices such as $41.60, $48.73 and $13.35 per share, and expirations extending to 2035, were cancelled under the transaction agreement. For each option, the holder receives cash equal to the in-the-money value: the difference between the $97.00 offer consideration and the exercise price, multiplied by the number of underlying shares. Following these adjustments, the director reports zero derivative securities, illustrating the standard cash-out mechanics applied to equity awards in this acquisition.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Share Option (right to buy) | 13,193 | $0.00 | -- |
| Disposition | Share Option (right to buy) | 8,844 | $0.00 | -- |
| Disposition | Share Option (right to buy) | 14,414 | $0.00 | -- |
| Disposition | Share Option (right to buy) | 16,604 | $0.00 | -- |
| Disposition | Share Option (right to buy) | 6,120 | $0.00 | -- |
| Disposition | Share Option (right to buy) | 8,631 | $0.00 | -- |
| Disposition | Share Option (right to buy) | 5,650 | $0.00 | -- |
| Disposition | Share Option (right to buy) | 4,983 | $0.00 | -- |
| Disposition | Share Option (right to buy) | 8,500 | $0.00 | -- |
| U | Common Shares | 73,576 | $97.00 | $7.14M |
Footnotes (1)
- On September 29, 2025, Merus N.V. (the "Issuer") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the "Transaction Agreement") with Genmab A/S ("Genmab") and its wholly owned subsidiary, Genmab Holding II B.V. (the "Purchaser"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the "Shares"), of the Issuer (the "Offer"), and, on December 12, 2025 (the "Acceptance Time"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including the Shares tendered by the reporting person, in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the "Offer Consideration"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time. This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option.
